Slate Path Capital’s NexImmune, Inc. Common Stock NEXI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-36,999
| Closed | -$102K | – | 70 |
|
|
2024
Q2 | $102K | Hold |
36,999
| – | – | ﹤0.01% | 55 |
|
|
2024
Q1 | $208K | Hold |
36,999
| – | – | ﹤0.01% | 59 |
|
|
2023
Q4 | $82.1K | Sell |
36,999
-1
| -0% | -$2 | ﹤0.01% | 57 |
|
|
2023
Q3 | $194K | Hold |
37,000
| – | – | 0.01% | 45 |
|
|
2023
Q2 | $261K | Hold |
37,000
| – | – | 0.01% | 44 |
|
|
2023
Q1 | $352K | Buy |
+37,000
| New | +$352K | 0.02% | 38 |
|
|
2022
Q4 | – | Sell |
-37,000
| Closed | -$513K | – | 51 |
|
|
2022
Q3 | $513K | Hold |
37,000
| – | – | 0.03% | 43 |
|
|
2022
Q2 | $1.49M | Hold |
37,000
| – | – | 0.09% | 38 |
|
|
2022
Q1 | $3.89M | Hold |
37,000
| – | – | 0.2% | 34 |
|
|
2021
Q4 | $4.26M | Hold |
37,000
| – | – | 0.22% | 32 |
|
|
2021
Q3 | $14M | Hold |
37,000
| – | – | 0.64% | 27 |
|
|
2021
Q2 | $15.1M | Hold |
37,000
| – | – | 0.84% | 23 |
|
|
2021
Q1 | $17.6M | Buy |
+37,000
| New | +$17.6M | 1.14% | 18 |
|